What should you know about targeted chemo for lung cancer?

The phrase targeted chemo is often used broadly, but targeted medicines differ from traditional chemotherapy. A tissue or blood sample may be examined through genomic tumour profiling to look for changes that a medicine can act on. The result helps the oncology team choose treatment, consider alternatives and understand when a different approach may be needed.

Treatment may be given as tablets, an infusion or a combination with other care. Side effects depend on the medicine and can include skin changes, diarrhoea, tiredness, mouth symptoms, blood-count changes or effects on organs. Follow-up may include scans, blood tests and discussion of symptoms.

Take tablets exactly as prescribed and do not change or stop them without guidance. Tell the team about all medicines, supplements and health conditions because interactions can alter treatment. Keep a daily record of doses and new symptoms. Ask how to handle missed doses, whether food affects the medicine, and how treatment fits with surgery, radiotherapy or supportive care.

Call the care team promptly for fever, severe diarrhoea, repeated vomiting, a new rash, worsening breathlessness, chest pain, marked weakness or yellowing of the skin. Seek emergency help for severe breathing difficulty, fainting, confusion or sudden weakness. A hoarse voice or other new symptom should also be reported, because the team may need to assess it rather than assume it is a treatment effect.

Which tumour change is being targeted? Is the medicine a tablet or infusion, and how will response be checked? Which side effects require a same-day call? Should close relatives be tested, or is this result limited to the tumour?